We’re proud to support International Health Partners
We’re proud to support International Health Partners 24th July 2023

Mawdsleys are proud to support International Health Partners, who have recently collaborated with Radio 4 in an appeal to raise much needed funds for their vital work.

 

The appeal was based on maternal health, and aimed to raise funds for essential medicines required during pregnancy and childbirth, to ensure expectant and new mums receive life-saving treatment if they need it. The countries helped include Honduras, Ethiopia, Gaza and Liberia.

 

International Health Partners rely on monetary donations and donations of quality, long-dated medicines and healthcare products from pharmaceutical companies to help people around the world who otherwise would not have access to basic healthcare.

 

Mawdsleys happily contributed to the appeal and are delighted to be able to support such a worthy cause.

 

Find out more about the work of International Health Partners here.

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-at-clinical-pharmacy-congress-2024/ thumbnail image Clinical Pharmacy Congress 2024

We recently exhibited at Clinical Pharmacy Congress at ExCel London. We were there to showcase how we innovate the world of pharma supply and distribution with:   Hospital Distribution Imported Unlicensed Medicines  Hospital Over-labelling  Healthcare Third Party Logistics   It was a very productive show and we had some great…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-meabco-launch-a-named-patient-supply-program-for-bp-c1/ thumbnail image Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Read more